Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations

Lebeda D, Fierenz A, Werfel L, Rosin-Arbesfeld R, Hofhuis J, Thoms S (2024)
Journal of Molecular Medicine 102: 641–653.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 5.96 MB
Autor*in
Lebeda, DennisUniBi; Fierenz, Adrian; Werfel, Lina; Rosin-Arbesfeld, Rina; Hofhuis, JuliaUniBi; Thoms, SvenUniBi
Abstract / Bemerkung
Rett syndrome (RTT) is a neurodevelopmental disorder resulting from genetic mutations in the methyl CpG binding protein 2 (MeCP2) gene. Specifically, around 35% of RTT patients harbor premature termination codons (PTCs) within the MeCP2 gene due to nonsense mutations. A promising therapeutic avenue for these individuals involves the use of aminoglycosides, which stimulate translational readthrough (TR) by causing stop codons to be interpreted as sense codons. However, the effectiveness of this treatment depends on several factors, including the type of stop codon and the surrounding nucleotides, collectively referred to as the stop codon context (SCC). Here, we develop a high-content reporter system to precisely measure TR efficiency at different SCCs, assess the recovery of the full-length MeCP2 protein, and evaluate its subcellular localization. We have conducted a comprehensive investigation into the intricate relationship between SCC characteristics and TR induction, examining a total of 14 pathogenic MeCP2 nonsense mutations with the aim to advance the prospects of personalized therapy for individuals with RTT. Our results demonstrate that TR induction can successfully restore full-length MeCP2 protein, albeit to varying degrees, contingent upon the SCC and the specific position of the PTC within the MeCP2 mRNA. TR induction can lead to the re-establishment of nuclear localization of MeCP2, indicating the potential restoration of protein functionality. In summary, our findings underscore the significance of SCC-specific approaches in the development of tailored therapies for RTT. By unraveling the relationship between SCC and TR therapy, we pave the way for personalized, individualized treatment strategies that hold promise for improving the lives of individuals affected by this debilitating neurodevelopmental disorder. KEY MESSAGES: The efficiency of readthrough induction at MeCP2 premature termination codons strongly depends on the stop codon context. The position of the premature termination codon on the transcript influences the readthrough inducibility. A new high-content dual reporter assay facilitates the measurement and prediction of readthrough efficiency of specific nucleotide stop contexts. Readthrough induction results in the recovery of full-length MeCP2 and its re-localization to the nucleus. MeCP2 requires only one of its annotated nuclear localization signals. © 2024. The Author(s).
Stichworte
Translational readthrough · Rare disease · Rett syndrome · MeCP2 · Personalized medicine · Aminoglycoside
Erscheinungsjahr
2024
Zeitschriftentitel
Journal of Molecular Medicine
Band
102
Seite(n)
641–653
eISSN
1432-1440
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Universität Bielefeld im Rahmen des DEAL-Vertrags gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2987678

Zitieren

Lebeda D, Fierenz A, Werfel L, Rosin-Arbesfeld R, Hofhuis J, Thoms S. Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations. Journal of Molecular Medicine. 2024;102:641–653.
Lebeda, D., Fierenz, A., Werfel, L., Rosin-Arbesfeld, R., Hofhuis, J., & Thoms, S. (2024). Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations. Journal of Molecular Medicine, 102, 641–653. https://doi.org/10.1007/s00109-024-02436-6
Lebeda, Dennis, Fierenz, Adrian, Werfel, Lina, Rosin-Arbesfeld, Rina, Hofhuis, Julia, and Thoms, Sven. 2024. “Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations”. Journal of Molecular Medicine 102: 641–653.
Lebeda, D., Fierenz, A., Werfel, L., Rosin-Arbesfeld, R., Hofhuis, J., and Thoms, S. (2024). Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations. Journal of Molecular Medicine 102, 641–653.
Lebeda, D., et al., 2024. Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations. Journal of Molecular Medicine, 102, p 641–653.
D. Lebeda, et al., “Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations”, Journal of Molecular Medicine, vol. 102, 2024, pp. 641–653.
Lebeda, D., Fierenz, A., Werfel, L., Rosin-Arbesfeld, R., Hofhuis, J., Thoms, S.: Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations. Journal of Molecular Medicine. 102, 641–653 (2024).
Lebeda, Dennis, Fierenz, Adrian, Werfel, Lina, Rosin-Arbesfeld, Rina, Hofhuis, Julia, and Thoms, Sven. “Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations”. Journal of Molecular Medicine 102 (2024): 641–653.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2025-11-14T07:27:52Z
MD5 Prüfsumme
edea82c4e00bf5572dd754ba7588cc13


Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 38430393
PubMed | Europe PMC

Suchen in

Google Scholar